Briefs

 - 
Sunday, February 29, 2004

Respironics quarterly sales at $192 million

MURRYSVILLE, Pa. - Respironics sales jumped to $192 million in the second quarter, exceeding last year’s sales in the same quarter by 27%. The revenue growth, the company said in a release, is all in-house since its most recent acquisitions were completed during the previous fiscal year. Domestic revenues totaled $143 million in the quarter, up 23% over last year. The company’s net income was $15.9 million. Respironics spent $1.5 million to establish the Respironics Sleep and Respiratory Research Foundation, which will be used to promote awareness of and research into the medical consequences of sleep and respiratory problems.
ResMed’s quarterly sales at $82 million

SAN DIEGO - ResMed racked up $82 million in revenues for the quarter that ended Dec. 31, up 26% over revenues for the same quarter the previous year. Net income for the quarter was $14 million, up 36%. ResMed spent $6.8 million, approximately 8% of revenue, on research and development for the quarter. That’s up 40% over R&D expenditures from the previous quarters and reflects ResMed’s ongoing interest in the development of products that address cardiovascular problems.
Acquisition bolsters Inva-care’s supplies business
ELYRIA, Ohio - Invacare has acquired the assets of ACS, a Deer Park, N.Y.-based division of Mediq PRN Life Support Services, which distributes medical supplies with a focus on infusion therapy. Terms of the cash purchase were not disclosed. The business of ACS will be combined with Invacare Supply Group’s current distribution business, which is headquartered in Holliston, Mass. ACS’ sales and customer service personnel will be employed by Invacare Supply Group. The ACS distribution system will be consolidated into ISG over the next few months.
Outtakes

Home Diagnostics, a manufacturer and marketer of blood glucose monitoring systems, announced in January that its TrueTrack Smart System and Prestige IQ Smart System has been included on the Florida Medicaid Preferred Drug List as of January 1, 2004.

Links: